Clarkston Capital Partners LLC Purchases 71,560 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Clarkston Capital Partners LLC raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,397,805 shares of the company's stock after purchasing an additional 71,560 shares during the quarter. Henry Schein makes up about 1.9% of Clarkston Capital Partners LLC's investment portfolio, making the stock its 17th largest position. Clarkston Capital Partners LLC owned approximately 1.10% of Henry Schein worth $101,900,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Thrivent Financial for Lutherans raised its position in Henry Schein by 1,848.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company's stock valued at $7,685,000 after purchasing an additional 100,006 shares during the last quarter. Natixis Advisors LLC raised its position in Henry Schein by 18.8% in the 3rd quarter. Natixis Advisors LLC now owns 81,877 shares of the company's stock valued at $5,969,000 after purchasing an additional 12,930 shares during the last quarter. Simplify Asset Management Inc. raised its position in Henry Schein by 61.6% in the 3rd quarter. Simplify Asset Management Inc. now owns 5,972 shares of the company's stock valued at $435,000 after purchasing an additional 2,277 shares during the last quarter. CIBC Asset Management Inc increased its stake in shares of Henry Schein by 7.0% in the 3rd quarter. CIBC Asset Management Inc now owns 17,680 shares of the company's stock valued at $1,289,000 after buying an additional 1,162 shares during the period. Finally, ING Groep NV acquired a new stake in shares of Henry Schein in the 3rd quarter valued at $63,226,000. Institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on HSIC shares. Baird R W raised Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Robert W. Baird lowered their target price on Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. Barrington Research reissued an "outperform" rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $78.89.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.14% of the company's stock.

Henry Schein Trading Up 7.5 %

NASDAQ:HSIC traded up $5.13 on Monday, reaching $73.89. The company's stock had a trading volume of 3,564,726 shares, compared to its average volume of 1,367,991. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market cap of $9.21 billion, a PE ratio of 30.41, a PEG ratio of 1.97 and a beta of 0.87. The business's 50-day moving average price is $70.40 and its two-hundred day moving average price is $69.61.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the previous year, the firm earned $1.32 earnings per share. The company's revenue was up .4% on a year-over-year basis. Equities research analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.